NAV
$23.55
AUM
$1.3M
Expense Ratio
-
Dividend Yield
0.00%
Beta
0.00
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +19.06% | +13.59% | +27.34% | +0.64% | - | - |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | AGX | Argan Inc | 16.74% |
| 2 | OSCR | Oscar Health Inc Class A | 4.36% |
| 3 | APAM | Artisan Partners Asset Management Inc Class A | 4.28% |
| 4 | COLL | Collegium Pharmaceutical Inc | 4.25% |
| 5 | ENVA | Enova International Inc | 4.21% |
| 6 | HCSG | Healthcare Services Group Inc | 3.35% |
| 7 | HRMY | Harmony Biosciences Holdings Inc Ordinary Shares | 3.23% |
| 8 | PJT | PJT Partners Inc Class A | 2.95% |
| 9 | NXT | Nextpower Inc Class A | 2.77% |
| 10 | LCII | LCI Industries Inc | 2.75% |
To pursue its investment objective, the fund invests, under normal market circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in component securities of the underlying index. The underlying index is a rules-based equity index designed to track the performance of the small-cap segment of U.S. publicly traded companies with strong free cash flow return on invested capital (“FCF-ROIC”), drawing from the Adviser’s exclusive research. The fund is non-diversified.
Inception Date: 2025-02-18